43 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Henderson, Behavioral Neurologist & Neuropsychiatrist in Stanford, CA?
Dr. Victor Henderson, MD is a Behavioral Neurologist & Neuropsychiatrist, who primarily practices in Stanford, CA. He has been practicing for over 43 years and is board certified. Dr. Henderson graduated from Johns Hopkins University School of Medicine and completed his residency at Jewish Hospital of Cincinnati Program. Dr. Henderson is fluent in English, and is currently seeing new patients. Dr. Henderson’s practice accepts Kaiser Permanente, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Henderson’s office at (650) 723-6469.
What are Areas of Expertise for Dr. Henderson?
Dr. Victor Henderson, MD is a highly-rated, board-certified Behavioral Neurologist & Neuropsychiatrist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Henderson empowers patients to confidently navigate their health journey, specializing in Alzheimer's Disease, Dementia, Memory Disorders, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Henderson is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Henderson go to medical school and complete their residency?
Residency: Jewish Hospital of Cincinnati Program
Medical School: Johns Hopkins University School of Medicine
Is Dr. Henderson board certified as a Behavioral Neurologist & Neuropsychiatrist?
Yes, Dr. Victor Henderson, MD is board certified by the American Board of Psychiatry and Neurology
What languages does Dr. Henderson speak?
Dr. Henderson and their clinical team can communicate with patients in the following languages:
English
What conditions does a Behavioral Neurologist & Neuropsychiatrist like Dr. Henderson typically treat?
As a Behavioral Neurologist & Neuropsychiatrist, Dr. Henderson diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Henderson. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Alzheimer's Disease
- Late-Onset Alzheimer's Disease
- Alzheimer's Disease Fact Sheet
- AD
- Alzheimer's Dementia
- Memory Loss Disease
- Sporadic Alzheimer's
- Alzheimer's in Older Adults
ICD-10 Codes:
- G309: Alzheimer's disease, unspecified
- G301: Alzheimer's disease with late onset
Also known as:
- Mild Cognitive Impairment
- MCI
- Early Memory Loss
- Pre-Dementia
ICD-10 Codes:
- G3184: Mild cognitive impairment of uncertain or unknown etiology
Also known as:
- Memory Loss
- Memory
- Amnesia
- Forgetfulness
- Loss of Recall
ICD-10 Codes:
- R413: Other amnesia
Also known as:
- Routine Adult Health Checkup
- Health Checkup
- Adult physical exam
- Annual wellness visit for adults
- General adult medical exam
ICD-10 Codes:
- Z0000: Encounter for general adult medical examination without abnormal findings
Also known as:
- Walking and Mobility Problems
- Walking Problems
- Gait Abnormalities
- Trouble Moving
- Mobility Issues
ICD-10 Codes:
- R269: Unspecified abnormalities of gait and mobility
Also known as:
- Dementia
- Cognitive decline
- Memory loss
- Brain disorder
ICD-10 Codes:
- F0390: Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
What procedures does a Behavioral Neurologist & Neuropsychiatrist like Dr. Henderson typically perform?
As a Behavioral Neurologist & Neuropsychiatrist, procedures performed by Dr. Victor Henderson may include:
- Aging Brain (Neuropsychological Testing)
- Cortical Basal Ganglionic Degeneration (CBGD)
- Deep Brain Stimulation
- Disturbance of Skin Sensation
- Electroencephalogram (EEG)
- Evoked Potential Testing
- Gait Simulation
- Greater Occipital Nerve (GON) Block
Please contact Dr. Henderson's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Henderson accept my insurance?
Dr. Henderson accepts most major insurance plans. Important: Please call our office at (650) 723-6469 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Henderson accept in Stanford, CA?
Dr. Henderson in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Cross Blue Shield of Michigan
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Kaiser Permanente
Medicare
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Henderson's office located?
Recognitions
Publications
Cognition, mood, and physiological concentrations of sex hormones in the early and late
, 2013
Long-term soy isoflavone supplementation and cognition in women A randomized, controlled trial
, 2012
Is there a link between gynecologic surgeries and Alzheimer disease?
, 2014
Components of air pollution and cognitive function in middle-aged and older adults in Los Angeles.
, 2014
Information and misinformation on hormone therapy and meningiomas
, 2013
Normative Data for the Tower of London Performance in Australian Midlife Women
, 2013
Supply and demand alysis of the current and future US neurology workforce.
Alzheimer's disease: Review of hormone therapy trials and implications for treatment and prevention
Memantine is Associated with Longer Survival than Donepezil
, 2013
Memory symptoms during the menopausal transition
, 2012
Estrogens and Alzheimer disease risk Is there a window of opportunity?
, 2012
Effects of physical activity on vasomotor symptoms
, 2012
Paying attention to memory
, 2012
Hormone levels and cognitive function in postmenopausal midlife women.
, 2012
Hormone therapy and the risk of stroke
, 2012
Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on
, 2012
Exploring the interaction between SNP genotype
, 2012
Oestrogen Alpha-Receptor Variant and Two-Year Memory Decline in Mid life Australian Women
, 2012
The practice of neurology, 2000-2010 Report of the AAN Member Research Subcommittee
, 2011
EFFECTS OF ENDOGENOUS AND EXOGENOUS ESTROGEN EXPOSURES IN MIDLIFE AND LATE
, 2011
Updated IMS recommendations on postmenopausal hormone therapy
, 2011
Executive functions in recently postmenopausal women
, 2011
Perimenopausal use of hormone therapy is associated with enhanced memory
, 2011
Godal hormones and cognitive aging: a midlife perspective.
, 2011
Action of estrogens in the aging brain: Dementia and cognitive aging
, 2010
Age of menopause and impact of climacteric symptoms by geographical region
, 2010
Postmenopausal hormone therapy: an Endocrine Society scientific statement.
, 2010
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
, 2010
Summary of the tiol Institute on Aging-sponsored conference on depressive symptoms
, 2010
Subtypes of Mild Cognitive Impairment
, 2010
Functiol magnetic resonce imaging and estrogen effects on the brain
, 2010
The Relationship Between Cognitive Function and Physical Performance in Older Women
, 2010
Estrogen and progestogen use in postmenopausal women
, 2010
Chapter 37: alexia and agraphia.
, 2010
Menopause and mitochondria: Windows into Estrogen effects on Alzheimer's disease risk and therapy
, 2010
Chapter 17: cognitive assessment in neurology.
, 2010
Aging, Estrogens, and Episodic Memory in Women
, 2009
Frontiers proposal. tiol Institute on Aging bench to bedside: estrogen as a case study
, 2009
Memory at midlife: perception and misperception
, 2009
Estrogens, Episodic Memory and Alzheimer's Disease: A Critical Update
, 2009
A prospective study of the association between endogenous hormones
, 2009
Subclinical atherosclerosis is weakly associated with lower cognitive function
, 2009
Menopause, cognitive ageing and dementia: practice implications.
, 2009
Mildly Elevated TSH and Cognition in Middle-Aged and Older Adults
, 2009
Hormones, Cognition and Dementia
Cognitive changes after menopause: Influence of estrogen
, 2008
Estrogen and progestogen use in postmenopausal women
, 2008
Alexia and agraphia - Contrasting perspectives of J.-M. Charcot and J. Hughlings Jackson
, 2008
Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes
, 2008
Cognition and cognitive aging
, 2007
Alzheimer's disease and other neurological disorders
, 2007
Surgical versus tural menopause: cognitive issues
, 2007
The Semantic Object Retrieval Test (SORT) in amnestic mild cognitive impairment
, 2007
Estrogen and progestogen use in peri- and postmenopausal women
, 2007
Comparison of performance on the CERAD neuropsychological battery of Hispanic patients
, 2007
Preventing cognitive decline in usual aging
, 2006
The Semantic Object Retrieval Test (SORT) in normal aging and Alzheimer disease
, 2006
Spring cleaning at MS: the amended and restated code of regulations
, 2006
The neurology of menopause
, 2006
Hormone therapy, timing of initiation
, 2006
Estrogen-containing hormon therapy and Alzheimer's disease risk
, 2006
Normative data for Australian midlife women on category fluency
, 2006
Normative visuospatial performance in Australian midlife women
, 2006
Menopause and disorders of the central nervous system.
, 2005
Estrogen and cognition, with a focus on Alzheimer's disease
, 2005
Effect of raloxifene on prevention of dementia and cognitive impairment in older women
, 2005
Only a matter of time? Hormone therapy and cognition
, 2005
Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age
, 2005
Diagnosis and treatment of Alzheimer's disease
, 2005
Normative data for tasks of executive function
, 2004
Telephone word-list recall tested in the Rural Aging and Memory Study
, 2004
A population-based study of depressed mood in middle-aged, Australian-born women
, 2004
Normative verbal and non-verbal memory test scores for Australian women aged 56-67
, 2004
Detecting dementia in just 12 minutes: the seven minute screen
, 2004
Hormone therapy and Alzheimer's disease: benefit or harm?
, 2004
Testosterone and Alzheimer disease - Is it men's turn now?
, 2004
Hormone therapy and Alzheimer disease: an evidence based approach to clinical magement.
, 2004
Serum lipids and memory in a population based cohort of middle age women
, 2003
Effect of estrogen plus progestin on global cognitive function in postmenopausal women
, 2003
Isoflavones: food for thoughtful consideration
, 2003
Estrogen exposures and memory at midlife - A population-based study of women
, 2003
DHEA for Alzheimer's disease - A modest showing by a superhormone
, 2003
White matter structural integrity in healthy aging adults
, 2003
Hormone therapy and risk of Alzheimer disease: a critical time.
, 2002
Dementia, butterfly ballots, and voter competence
, 2002
Better preservation of memory span relative to supraspan immediate recall in Alzheimer's disease
, 2002
Clock drawing: Alysis in a retirement community
, 2001
Assessing working memory and language comprehension in Alzheimer's disease
, 2001
Hormones, Gender and the Aging Brain
, 2001
Associations between circulating sex steroid hormones and cognition in normal elderly women
, 2000
Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
, 2000
In vivo evaluation of brain iron in Alzheimer disease using magnetic resonce imaging
, 2000
Hormone Therapy and the Brain
Estrogen and neural plasticity.
, 2000
Oestrogens and dementia.
, 2000
Anosognosia and Alzheimer's disease: The role of depressive symptoms in mediating impaired insight
, 2000
Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease
, 1999
Does estrogen therapy enhance memory?
, 1999
Estrogen replacement therapy and Alzheimer's disease
, 1998
Hormonothérapie substitutive et maladie d?Alzheimer.
, 1998
Sex steroids and Alzheimer?s disease: therapeutic considerations.
, 1998
Alzheimer?s disease and other dementias in the older woman.
, 1998
Principles of Neurology, 6th ed. By RD Adams, M Victor, and AH Ropper.
, 1998
Lifetime estrogen exposure and cognitive performance in elderly women
, 1997
Estrogen, cognition, and a woman's risk of Alzheimer's disease.
, 1997
The relationship between extrapyramidal signs
, 1997
Body weight, estrogen and cognitive functioning in Alzheimer's disease
, 1997
The epidemiology of estrogen replacement therapy and Alzheimer's disease
, 1997
Ageing, oestrogen and the brain
, 1997
Estrogen and Alzheimer's disease
, 1997
Estrogen replacement therapy for the prevention and treatment of Alzheimer?s disease
, 1997
A comparative alysis of Spanish- and English-speaking Alzheimer?s disease patients
, 1997
Estrogen replacement therapy and risk of Alzheimer disease
, 1996
Introduction. The investigation of lexical semantic representation in Alzheimer's disease.
, 1996
Spouses of demented patients with low cobalamin levels: A new risk group for cobalamin deficiency
, 1996
The effects of hormone replacement therapy, lipoprotein cholesterol levels
, 1996
Concurrent validity of Spanish-language versions of the Mini-Mental State Examition
, 1996
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
, 1996
Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease
, 1996
Cognitive skills associated with estrogen replacement in women with Alzheimer's disease
, 1996
Memory span procedures in Alzheimer's disease
, 1996
The consortium to establish a registry for Alzheimer's disease
, 1996
Full-information models for multiple psychometric tests
, 1996
Memory?span procedures in Alzheimer?s disease
, 1996
OCCUPATIONS WITH EXPOSURE TO ELECTROMAGNETIC-FIELDS - A POSSIBLE RISK FACTOR FOR ALZHEIMERS-DISEASE
, 1995
P300 TOPOGRAPHY IN ALZHEIMERS-DISEASE
, 1995
THE FREQUENTLY LOW COBALAMIN LEVELS IN DEMENTIA USUALLY SIGNIFY TREATABLE METABOLIC
, 1995
Occupatiol exposure to electromagnetic fields: A possible risk factor for Alzheimer's disease
, 1995
LINGUISTIC AND ATTENTIOL CONTRIBUTIONS TO ANOMIA IN ALZHEIMERS-DISEASE
, 1995
Henderson VW. The Mental Status Examition in Neurology, 3rd. ed. By RL Strub and FW Black
, 1995
The frequently low cobalamin levels in dementia usually signify treatable metabolic
, 1995
Linguistic and attentiol contributions to anomia in Alzheimer's disease
, 1995
ESTROGEN REPLACEMENT THERAPY IN OLDER WOMEN - COMPARISONS BETWEEN ALZHEIMERS
, 1994
ESTROGEN DEFICIENCY AND RISK OF ALZHEIMERS-DISEASE IN WOMEN
, 1994
COGNITIVE DEFICITS OF MEN AND WOMEN WITH ALZHEIMERS-DISEASE
, 1994
GENDER DIFFERENCES ON A BRIEF MEASURE OF COGNITIVE-FUNCTIONING IN ALZHEIMERS-DISEASE
, 1993
Sigmund Freud and the diagram-maker school of aphasiology.
, 1992
BOSTON MING TEST - SHORTENED VERSIONS FOR USE IN ALZHEIMERS-DISEASE
, 1992
THE AGRAPHIA OF ALZHEIMERS-DISEASE
, 1992
The agraphia of Alzheimer's disease.
, 1992
NEUROMAGNETIC LOCALIZATION USING MAGNETIC-RESONCE IMAGES
, 1992
Spanish translation and validation of a neuropsychological battery
, 1992
Neuromagnetic localization using magnetic resonce images
, 1992
Early concepts of conduction aphasia.
, 1992
SEVERITY OF DEMENTIA IN ALZHEIMER-DISEASE AND NEUROFIBRILLARY TANGLES IN MULTIPLE BRAIN-REGIONS
, 1991
Stimulant drug treatment of the attention deficit disorder.
, 1991
Studies in Disorders of Communication. By Y Lebrun
, 1991
Diagnosis of Alzheimer Disease and Other Dementias
MING CONSISTENCY IN ALZHEIMERS-DISEASE
, 1990
LIPOMAS OF THE MESENCEPHALIC TECTUM AND ROSTRAL PONS ASSOCIATED WITH SLEEP-APNEA SYNDROME
, 1990
SQUID neuromagnetic reconstruction of brain activity.
, 1990
ALALIA, APHEMIA, AND APHASIA
, 1990
Neuromagnetic localization using magnetic resonce images.
, 1990
ALZHEIMERS DEMENTIA - PERFORMANCE ON PARALLEL FORMS OF THE DEMENTIA ASSESSMENT BATTERY